Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
RSC Adv ; 14(34): 24898-24909, 2024 Aug 05.
Article in English | MEDLINE | ID: mdl-39119280

ABSTRACT

Mono-/dimeric-substituted pyridinium and pyrazolium bromides were prepared under conventional and solvent-free silica-supported domestic microwave conditions. The atom economy, environmental product mass intensity and product mass intensity for solvent-free reactions showed significant importance for the synthesis of target molecules. 4-Nitrobenzyl-substituted pyridinium bromide showed potent anticancer properties compared with mono-/dimeric-substituted pyridinium and pyrazolium bromides against a lung cancer cell line (A-549). Molecular simulation studies were carried out for mono-/dimeric-substituted pyridinium and pyrazolium bromide against protein human CDK1/cyclinB1/CKS2 using the AutoDock program.

2.
Int J Biol Macromol ; 278(Pt 3): 134769, 2024 Oct.
Article in English | MEDLINE | ID: mdl-39151866

ABSTRACT

Heavy metal pollution poses a significant environmental challenge to worldwide, especially in developing countries. This study focuses on eliminating the heavy metal chromium (VI) ion from wastewater, employing an eco-friendly and economical ternary blend composed of Chitosan (CS), Carboxymethyl cellulose (CMC), and bioactive glass (BAG). The innovative bioactive glass is crafted from biosilica extracted from biowaste of cow dung ash, calcium oxide from eggshell ash, and phosphorus pentoxide. The CS/CMC/BAG blend is prepared via sol-gel method and characterized using XRD, FT-IR, TGA, BET, TEM and SEM revealing a porous structural morphology during blending. Batch adsorption studies explore various parameters such as pH, adsorbent dose, contact time and initial metal ion concentrations. The results are then evaluated through adsorption kinetics and adsorption isotherms (Langmuir, Freundlich, D-R, and Temkin isotherm modeling). The investigation concludes that the optimal conditions for Cr (VI) removal are pH 3, contact time of 300 min, adsorbent dosage of 0.5 g, and an initial metal ion concentration of 50 ppm. The adsorption isotherm model indicates an excellent fit with the Freundlich isotherm (R2 = 0.9576) and pseudo-second-order kinetics (R2 = 0.981). In summary, the CS/CMC/BAG ternary blend exhibits a remarkable ability to effectively remove heavy metal Cr(VI) ions from industrial wastewater.


Subject(s)
Carboxymethylcellulose Sodium , Chitosan , Chromium , Glass , Water Pollutants, Chemical , Chitosan/chemistry , Carboxymethylcellulose Sodium/chemistry , Chromium/chemistry , Adsorption , Glass/chemistry , Water Pollutants, Chemical/chemistry , Kinetics , Hydrogen-Ion Concentration , Water Purification/methods , Wastewater/chemistry , Metals, Heavy/chemistry
3.
Semin Cancer Biol ; 69: 43-51, 2021 02.
Article in English | MEDLINE | ID: mdl-31618687

ABSTRACT

The applications of gene therapy-based treatment of cancers were started almost two decades back as a boon over the chemotherapeutic treatment strategies. Gene therapy helps in correcting the genetic sequences for treatment of cancers, thus also acts like a vaccine to induce the cellular and humoral immunity. However, the cancer vaccines typically suffer from a series of biopharmaceutical challenges due to poor solubility, low systemic availability and lack of targeting ability. Owing to these challenges, the physicians and pharmaceutical scientists have explored the applications of nanocarriers as quite promising systems for effective treatment against the tumors. A series of nanotherapeutic systems are available to date for diverse drug therapy applications. Systematic understanding on the preparation, evaluation and application of nanomedicines as a carrier system for delivering the cancer vaccines is highly important. The present review article provides an in-depth understanding on the challenges associated with cancer vaccine delivery and current opportunities with diverse nanomedicinal carriers being available for treatment of cancers.


Subject(s)
Antineoplastic Agents/administration & dosage , Cancer Vaccines/administration & dosage , Drug Delivery Systems , Nanomedicine , Neoplasms/drug therapy , Vaccination/methods , Animals , Humans , Neoplasms/pathology
4.
Biomed Res Int ; 2020: 2562950, 2020.
Article in English | MEDLINE | ID: mdl-32566673

ABSTRACT

The spermatozoa are transcriptionally dormant entities which have been recognized to be an archive of mRNA, coding for a variety of functionally crucial cellular proteins. This significant repository of mRNA is predicted to be associated with early embryogenesis and postfertilization. The mRNA transcripts which are tagged with minisatellites have been involved in the regulation of the gene functions as well as their organization. However, very little information is available regarding the expression of the transcripts tagged with minisatellites in spermatozoa. Therefore, in order to understand the functions and the conformational behavior of the proteins expressed from these minisatellite-tagged transcripts, we have performed a detailed in silico analysis using the sequences of the transcripts. The protein predicted from KF274549 showed the functionalities similar to uncharacterized C4orf26 proteins, while that obtained from KF274557 predicted to be a metallophosphoesterase. Furthermore, the structural folds in the structure of these predicted proteins were analyzed by using the homology modeling and their conformational behaviors in the explicit water conditions were analyzed by using the techniques of Molecular Dynamics (MD) simulations. This detailed analysis will facilitate the understanding of these proteins in the spermatozoon region and can be used for uncovering other attributes of the metabolic network.


Subject(s)
Minisatellite Repeats/genetics , Phosphoprotein Phosphatases , Carrier Proteins/chemistry , Carrier Proteins/classification , Carrier Proteins/genetics , Carrier Proteins/metabolism , Humans , Molecular Dynamics Simulation , Nuclear Proteins/chemistry , Nuclear Proteins/classification , Nuclear Proteins/genetics , Nuclear Proteins/metabolism , Phosphoprotein Phosphatases/chemistry , Phosphoprotein Phosphatases/classification , Phosphoprotein Phosphatases/genetics , Phosphoprotein Phosphatases/metabolism , Protein Conformation , Proto-Oncogene Proteins c-akt
SELECTION OF CITATIONS
SEARCH DETAIL